RxDoctor Payments Data

Pavan Dontineni, MD

Psychiatry · Columbus, OHNPI 1790944866

Payments from drug & device makers

$31,917in general payments, 2019–2025

Across 194 payments — averaging $164.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$30K
  • Otsuka America Pharmaceutical, Inc.$387
  • Sunovion Pharmaceuticals Inc.$273
  • Axsome Therapeutics, Inc.$214
  • Alkermes, Inc.$143
  • Johnson & Johnson$112
  • plus $525 from 11 others

What the payments were for

  • Speaking & faculty fees$29,05091%
  • Food & beverage$2,8529%
  • Education$150%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,917 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio

Medicare billing

Part B allowed, 2024
$25,875
Medicare patients
83
Services billed
225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine14$211,589
AristadaAripiprazole Lauroxil49$159,737
Invega SustennaPaliperidone Palmitate46$135,257
VraylarCariprazine Hcl55$74,395
Abilify MaintenaAripiprazole13$34,351
RexultiBrexpiprazole19$28,639
ClozarilClozapine14$16,573
TrintellixVortioxetine Hydrobromide22$10,597
Lurasidone Hcl33$6,081
Chlorpromazine Hcl21$4,782
Divalproex Sodium ErDivalproex Sodium69$4,581
Olanzapine28$3,511
Aripiprazole47$2,564
Vilazodone Hcl15$2,211
Paliperidone ErPaliperidone16$2,020

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$61$211,58914 claims
Alkermes, Inc.Aristada$143$159,73749 claims
Johnson & JohnsonInvega Sustenna$112$135,25746 claims
AbbVieVraylar$30,263$74,39555 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$387$62,99032 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,119 psychiatry providers in Ohio.

Other psychiatry in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →